Can I take tramadol while breastfeeding, and what dosing and monitoring precautions are needed for a healthy term infant older than two weeks versus a newborn or premature infant?

Tramadol and Breastfeeding

Tramadol can be used with extreme caution during breastfeeding, but should be restricted to inpatient settings only, with limited total dose and duration, while closely monitoring the infant for respiratory depression, increased sleepiness, sedation, and decreased alertness. 1

Critical Safety Considerations

The evidence presents a significant divergence between regulatory bodies that must be acknowledged:

• FDA Warning (2017): Issued a statement warning against tramadol use while breastfeeding due to case reports of respiratory depression and death 1
• UK DILAS Position: Despite the FDA warning, recommends tramadol can continue to be used with caution during breastfeeding 1

The key issue is that tramadol and its active metabolite O-desmethyltramadol are both excreted into breast milk, and there have been documented cases of infant respiratory depression and death. 1

Practical Dosing and Monitoring Framework

For Healthy Term Infants >2 Weeks Old:

If tramadol must be used:

• Restrict use to inpatient settings only where both mother and infant can be monitored 1
• Limit the total dose - avoid repeated dosing 1
• Use the lowest effective dose for the shortest duration possible 1
• Monitor the infant continuously for:
  • Increased sleepiness
  • Signs of respiratory depression
  • Sedation and decreased alertness
  • Difficulty feeding 1
• Also monitor the mother for excessive opioid effects, as maternal symptoms may predict infant risk 1

For Newborns and Premature Infants:

Tramadol should be avoided entirely in this population. The evidence shows particular concern for very young infants - one case report documented a 6-day-old infant (exposed to hydromorphone, but illustrating vulnerability of this age group) who developed respiratory depression requiring naloxone 1. Newborns and premature infants have:

• Immature hepatic metabolism
• Reduced drug clearance
• Greater vulnerability to respiratory depression
• Higher risk of accumulation of both tramadol and its active metabolite

Quantitative Exposure Data

Research provides some reassurance but must be interpreted cautiously:

• At steady-state, the combined relative infant dose is approximately 2.88% of the maternal weight-adjusted dose 2
• Absolute infant doses ranged from 10-294 μg/kg/day depending on timing and maternal dose 3
• Milk:plasma ratios are 2.2 for tramadol and 2.8 for O-desmethyltramadol, indicating concentration in breast milk 2

However, these "low" percentages do not eliminate risk - the documented cases of respiratory depression and death demonstrate that even small exposures can be dangerous in vulnerable infants 1.

Critical Pitfalls to Avoid

1. Outpatient prescribing: Never prescribe tramadol for home use in breastfeeding women - the inability to monitor the infant creates unacceptable risk 1

2. Repeated dosing: Avoid scheduled or prolonged tramadol administration - if used, limit to single or minimal doses 1

3. Ignoring maternal symptoms: Excessive maternal sedation or side effects predict higher infant exposure and risk 1

4. Assuming safety in older infants: While term infants >2 weeks are less vulnerable than newborns, risk remains present at all ages during breastfeeding

Safer Alternatives

Consider these options first 1:

• Paracetamol: Safe, infant exposure well below therapeutic doses
• Ibuprofen: Extensively studied, considered safe during breastfeeding
• Diclofenac: Small amounts in milk, safe with extensive use
• Morphine (if strong opioid needed): Recommended as opioid of choice for breastfeeding women requiring strong analgesia, with appropriate monitoring 1
• Dihydrocodeine: Preferred weak opioid over tramadol due to cleaner metabolism 1

Avoid codeine entirely - it carries similar or greater risks due to unpredictable CYP2D6 metabolism 1

The Bottom Line

Given the documented fatalities, FDA warning, and availability of safer alternatives, tramadol should only be used during breastfeeding when no other analgesic option is appropriate, and only in a monitored inpatient setting with continuous infant observation. For outpatient pain management in breastfeeding women, choose alternative analgesics. The theoretical "low" infant dose does not override the real-world cases of severe harm and death.